Purchase Order 1232SD18P0433
Award Date 7/13/18
Potential Completion Date 7/20/18
Potential Value $15K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Princeton, NJ, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Medchemexpress LLC, a foreign-owned, minority-owned, self-certified small disadvantaged business. The $10,700 contract is for the provision of commercial chemical and drug reagents, with a period of performance ending on July 28, 2026. Medchemexpress is a New Jersey-based company that specializes in supplying chemical compounds, research materials, and scientific synthesis...
- Medchemexpress LLC was awarded a firm fixed price purchase order valued at seventy-seven thousand one hundred ninety-three dollars and forty-one cents ($77,193.41) by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to deliver one chemical library of five hundred nine bioactive compounds. The award originated from a sources sought notice issued by the National Institutes of Health's National Center for Advancing Translational...
- The National Center for Advancing Translational Sciences, a component of the U.S. Department of Health and Human Services' National Institutes of Health, awarded a $22,226.00 firm fixed price purchase order to MedChemExpress LLC, a New Jersey-based provider of life science research materials. The contract is to obtain 5-milligram samples of biologically active small molecules with well-defined mechanisms of action. This material will be used to create the MIPE 5.1 molecular library, a collection...
- This $113,163 federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Center for Advancing Translational Sciences to MedChemExpress LLC, a New Jersey-based provider of biochemicals, bioactive compounds, peptides, and other life science research materials. The contract is for the delivery of 75 chemical compounds to support ongoing COVID-19 research. The award was made via a purchase order under a non-competitive combined...
- This $16,035 firm-fixed price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a New Jersey-based foreign-owned minority-owned small business. The award is for the acquisition of 2 grams of Minnelide (CAS: 1254702-87-8) and 10 grams of GNE-618 (CAS: 1362151-42-5), which are chemical compounds used to support NCATS' biomedical research programs. MedChemExpress has...
- This federal contract was awarded by the National Institutes of Health (NIH), which is a component of the Department of Health and Human Services (HHS), to MedChemExpress LLC, a New Jersey-based provider of biochemicals, bioactive compounds, and other life science research materials. The contract is for the custom synthesis of 30 grams of a single chemical intermediate, with a period of performance from July 2, 2021, to September 1, 2021. The award is a firm-fixed-price purchase order with a...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Elsevier B.V., doing business as North-Holland (Publishing), for a PharmacoKinetic and Metabolizing Enzyme Modules subscription. The contract has a potential value of $529,066.01 and a completion date of September 29, 2021. The contract provides the FDA Library with unlimited online access to Elsevier's databases, including drug safety and efficacy data, to support...
- This firm-fixed-price purchase order, valued at $24,263.00, was awarded by the Food and Drug Administration (FDA) to Wuxi Apptec (Hongkong) LIMITED, a global provider of R&D and manufacturing services for the pharmaceutical and healthcare industry. The contract supports the mission of the Division of Toxicology (DOT) within the Office of Applied Research and Safety Assessment (OARSA) at the FDA's Center for Food Safety and Applied Nutrition (CFSAN). Wuxi Apptec will provide chemical...
- The Department of Health and Human Services Food and Drug Administration awarded a $207,623 purchase order to Clarivate Analytics (Us) LLC for ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION. Under this firm fixed price contract, Clarivate Analytics will provide data acquisition services to the FDA relating to API manufacturers. Performance will take place in Silver Spring, Maryland over approximately one year, from September 2023 through September 2024. As the regulator of...